RAIR Thyroid Cancer Research (January 30th, 2026)
RAIR Thyroid Cancer Research di John Londt
S1 · E2
30 gen 2026
17:27
Note sull'episodio
- Advances in Immunotherapy for Thyroid Malignancies: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1754058/full
- "Living Sentinel" Implant for Continuous Thyroid Monitoring: https://www.cmu.edu/news/stories/archives/2026/january/inside-cmus-push-to-transform-treatment-for-cancer-organ-failure-and-chronic-disease
- Fatty Acid Metabolism Drives Bone Metastasis: https://www.mdanderson.org/cancerwise/new-research-advances-in-our-understanding-of-cancer-metabolism.h00-159852189.html
- Cryoablation of Bone Metastases in Thyroid Cancer: https://pubmed.ncbi.nlm.nih.gov/41543023/
- Sugary Drinks Reprogram Metabolism to Drive Metastasis: https://www.mdanderson.org/cancerwise/new-research-advances-in-our-understanding-of-cancer-metabolism.h00-159852189.html
- AI in Screening Cuts Interval Cancer Rates by 12%: https://www.theguardian.com/science/2026/jan/29/ai-use-in-breast-cancer-screening-cuts-rate-of-later-diagnosis-by-12-study-finds
- First Immunotherapy (Retifanlimab) Recommended for Advanced Anal Cancer: https://www.ema.europa.eu/en/news/first-immunotherapy-based-treatment-recommended-advanced-anal-cancer
- Circulating Tumor DNA (ctDNA) in Germ Cell Tumors: https://ascopubs.org/journal/jco
- Pancreatic Cancer’s "Sugar Cloak" Decoded: https://news.northwestern.edu/
- Nuvalent "OnTarget 2026" Plan for RET Inhibitors: https://investors.nuvalent.com/
Parole chiave
thyroid cancer